Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-10

FDA Approved: EXEMESTANE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Exemestane from Zydus Pharmaceuticals USA Inc., updating an existing approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exemestane (Exemestane)

Snippet

SUPPL AP for EXEMESTANE (EXEMESTANE)